Slideshows

The SGLT-2 inhibitor class, originally approved as antihyperglycemic agents for T2D, has proven "pluripotent," adding indications for related conditions. Test your knowledge of a few basic facts.

Few common pain conditions have been as vexing to both patients and physicians as phantom limb pain. In our new slideshow, get a primer on prevention, treatment, pharmacotherapy, and more.